The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA ...
Courtney Luyando of Seymour lost her son Greyson, 12, to leukemia in May and decided to run her first marathon in Hartford ...
City of Hope® Research Spotlight offers a glimpse into groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, ...
Ziftomenib showed significant efficacy in relapsed/refractory NPM1-mutant AML, achieving deep, durable responses in the KOMET-001 trial. The trial enrolled 92 patients, with 23% achieving complete ...
Loriana Hernández-Aldama is an Emmy award winning journalist. For more than 25 years, she was a health and medical reporter and news anchor around the country. She is a breast cancer and leukemia ...
Brayden Cabral has been in remission for some time but he serves as inspirations for others who have gone or will go through a similar experience.
The selection of patients for allo-HSCT and the best approach to bridging patients to transplantation is continuously ...
Spontaneous regression is most commonly reported in neuroblastoma and leukemia. Case series link infection, transfusion, and ...
Like most teenage girls, Zuza Beine of Waukesha loved TikTok dances, Taylor Swift, and makeup.An avid collector of Jellycat stuffed animals and Lego sets, Beine also spent time ...
A research team at Lund University in Sweden has discovered a mechanism that helps acute myeloid leukemia cells to evade the body's immune system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results